PCN18 Matching-Adjusted Indirect Comparison (MAIC) of Entrectinib Versus Crizotinib in Patients with ROS1 NON-SMALL CELL LUNG Cancer (NSCLC): An Updated Analysis
Abstract
Authors
P. Chu C.R. Mitchell S. Batson A. Aziez M. Antoniou